Inhibition of glycogen synthase kinase-3 enhances the differentiation and reduces the proliferation of adult human olfactory epithelium neural precursors

被引:18
|
作者
Manceur, Aziza P. [1 ,2 ]
Tseng, Michael [3 ,4 ,5 ]
Holowacz, Tamara [2 ]
Witterick, Ian [5 ,6 ]
Weksberg, Rosanna [5 ,7 ]
McCurdy, Richard D. [7 ]
Warsh, Jerry J. [3 ,4 ,5 ]
Audet, Julie [1 ,2 ]
机构
[1] Univ Toronto, IBBME, Toronto, ON, Canada
[2] Univ Toronto, Donnelly Ctr, Toronto, ON, Canada
[3] Univ Toronto, CAMH, Lab Cellular & Mol Pathophysiol, Toronto, ON, Canada
[4] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[5] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada
[6] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5S 1A1, Canada
[7] Hosp Sick Children, Res Inst, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada
基金
加拿大健康研究院;
关键词
Stem cell; GSK-3; Olfactory mucosa; TAT(47-57); Differentiation; EMBRYONIC STEM-CELLS; NEURONAL DIFFERENTIATION; SCHIZOPHRENIC-PATIENTS; FRONTAL-CORTEX; IN-VITRO; PROGENITORS; GSK-3-BETA; LITHIUM; DISEASE; NEUROGENESIS;
D O I
10.1016/j.yexcr.2011.06.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The olfactory epithelium (OE) contains neural precursor cells which can be easily harvested from a minimally invasive nasal biopsy, making them a valuable cell source to study human neural cell lineages in health and disease. Glycogen synthase kinase-3 (GSK-3) has been implicated in the etiology and treatment of neuropsychiatric disorders and also in the regulation of murine neural precursor cell fate in vitro and in vivo. In this study, we examined the impact of decreased GSK-3 activity on the fate of adult human OE neural precursors in vitro. GSK-3 inhibition was achieved using ATP-competitive (6-bromoindirubin-3'-oxime and CHIR99021) or substrate-competitive (TAT-eIF2B) inhibitors to eliminate potential confounding effects on cell fate due to off-target kinase inhibition. GSK-3 inhibitors decreased the number of neural precursor cells in OE cell cultures through a reduction in proliferation. Decreased proliferation was not associated with a reduction in cell survival but was accompanied by a reduction in nestin expression and a substantial increase in the expression of the neuronal differentiation markers MAP1B and neurofilament (NF-M) after 10 days in culture. Taken together, these results suggest that GSK-3 inhibition promotes the early stages of neuronal differentiation in cultures of adult human neural precursors and provide insights into the mechanisms by which alterations in GSK-3 signaling affect adult human neurogenesis, a cellular process strongly suspected to play a role in the etiology of neuropsychiatric disorders. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:2086 / 2098
页数:13
相关论文
共 50 条
  • [21] QSAR studies for the pharmacological inhibition of glycogen synthase kinase-3
    Duchowicz, Pablo R.
    Castro, Eduardo A.
    MEDICINAL CHEMISTRY, 2007, 3 (04) : 393 - 417
  • [22] Glycogen synthase kinase-3β positively regulates the proliferation of human ovarian cancer cells
    Qi Cao
    Xin Lu
    You-Ji Feng
    Cell Research, 2006, 16 : 671 - 677
  • [23] Glycogen synthase kinase-3β inhibition attenuates asthma in mice
    Bao, Zhang
    Lim, Shuhui
    Liao, Wupeng
    Lin, Yuzhi
    Thiemermann, Christoph
    Leung, Bernard P.
    Wong, W. S. Fred
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 176 (05) : 431 - 438
  • [24] Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
    Manuel Dominguez, Juan
    Fuertes, Ana
    Orozco, Leyre
    del Monte-Millan, Maria
    Delgado, Elena
    Medina, Miguel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (02) : 893 - 904
  • [25] Inhibition of glycogen synthase kinase-3β and pancreatic cancer cell proliferation in vitro by citrus flavonoids
    Johnson, Jodee
    de Mejia, Elvira Gonzalez
    FASEB JOURNAL, 2011, 25
  • [26] GLYCOGEN SYNTHASE KINASE-3 INHIBITION ENHANCES C-KIT plus CELL PROLIFERATION AND POST-ISCHEMIC CARDIAC REPAIR
    Qassim, O. E.
    Kamkar, M.
    Molgat, A.
    Jambi, M. M.
    Ye, B.
    Latham, N.
    Davis, D. R.
    CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S345 - S345
  • [27] Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth
    Carter, Yvette M.
    Kunnimalaiyaan, Selvi
    Chen, Herbert
    Gamblin, T. Clark
    Kunnimalaiyaan, Muthusamy
    CANCER BIOLOGY & THERAPY, 2014, 15 (05) : 510 - 515
  • [28] Raf Kinase Inhibitor Protein RKIP Enhances Signaling by Glycogen Synthase Kinase-3β
    Al-Mulla, Fahd
    Bitar, Milad S.
    Al-Maghrebi, May
    Behbehani, Abdulla I.
    Al-Ali, Waleed
    Rath, Oliver
    Doyle, Brendan
    Tan, Kit Yee
    Pitt, Andrew
    Kolch, Walter
    CANCER RESEARCH, 2011, 71 (04) : 1334 - 1343
  • [29] Glycogen synthase kinase-3 as a gatekeeper of human cartilage degradation
    Litherland, G. J.
    Elias, M. S.
    Curtis, H.
    Rowan, A. D.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2012, 93 (04) : A31 - A31
  • [30] Expression analysis of glycogen synthase kinase-3 in human tissues
    Lau, KF
    Miller, CCJ
    Anderton, BH
    Shaw, PC
    JOURNAL OF PEPTIDE RESEARCH, 1999, 54 (01): : 85 - 91